United States HB2387

No Federal funds may be made available for purposes of paying for, sponsoring, promoting, assisting, or supporting the furnishing of a sex-trait altering treatment to a minor.

No Federal funds may be made available for purposes of taking any regulatory or subregulatory action to promote sex-trait altering treatments to minors.

Section 116 of title 18, United States Code, is 5 amended by adding at the end the following: ‘‘For the pur6 pose of subsection (b)(1), the phrase ‘‘necessary to the health of the person’’ shall not include change of gender or sex, or affirmation of gender or sex.’’.

No Federal funds may be made available to a medical institution (including a hospital, medical school, clinic, public health organization, federally qualified health center, rural health center, or medical practice) if such institution provides sex-trait altering treatments to minors.

The parent of a minor shall have the right to decline any sex-trait altering treatment for such minor. Likewise, no specified Federal funds shall be made available to a State that has in place a policy to provide sex-trait altering treatment for a minor without the consent of both parents.

No specified Federal funds may be made available to a State that has in place a policy to separate a minor from such minor’s par2 ent based solely on such parent’s refusal to consent to a sex-trait altering treatment for such minor.

A minor or a parent of a minor who is harmed by a violation of this section may bring a civil action against the United States and against any State with a policy in place in viola15 tion of this section in an appropriate district court of the United States to obtain appropriate relief.

An individual may bring a civil action in an appropriate district court of the United States to obtain appropriate relief for any physical, psychological, or physiological harm caused by a sex-trait altering treat24 ment performed on the individual when the individual was a minor against a medical practitioner, hospital, clinic, surgery center or other provider that performed or pre2 scribed such treatment. If said civil action is successful, the individual will be awarded attorney’s fees and litiga4 tion costs, and treble damages.

A health care provider may not be penalized, retaliated against, or otherwise discriminated against on the basis that the provider does not or declines to— (1) perform, refer for, pay for, or otherwise participate in sex-trait altering treatment; (2) provide or sponsor sex-trait altering treatment coverage; or (3) facilitate or make arrangements for sextrait altering treatment.